ARS Pharmaceuticals, Inc. Insider Transactions
ARS Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Chakma Justin
Chief Business Officer |
Sell | 32,814 @ $14.00 | $459,422 | 203,566 | 11/25/2024 | 11/27/2024 | |
| Sell | 50,000 @ $13.95 | $697,450 | 1,198,499 | 11/19/2024 | 11/21/2024 | ||
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 50,000 @ $13.95 | $697,450 | 1,198,499 | 11/19/2024 | 11/21/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 45,045 @ $16.76 | $754,905 | 1,301,449 | 11/12/2024 | 11/14/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 4,955 @ $17.64 | $87,421 | 1,296,494 | 11/12/2024 | 11/14/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 45,124 @ $16.76 | $756,296 | 1,253,375 | 11/12/2024 | 11/14/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 4,876 @ $17.64 | $86,020 | 1,248,499 | 11/12/2024 | 11/14/2024 | |
| Sell | 45,045 @ $16.76 | $754,905 | 1,301,449 | 11/12/2024 | 11/14/2024 | ||
| Sell | 4,955 @ $17.64 | $87,421 | 1,296,494 | 11/12/2024 | 11/14/2024 | ||
| Sell | 45,124 @ $16.76 | $756,296 | 1,253,375 | 11/12/2024 | 11/14/2024 | ||
| Sell | 4,876 @ $17.64 | $86,020 | 1,248,499 | 11/12/2024 | 11/14/2024 | ||
|
Flynn James E
10 percent owner |
Sell | 7,853 @ $17.16 | $134,757 | 5,266,883 | 11/12/2024 | 11/13/2024 | |
|
Flynn James E
10 percent owner |
Sell | 7,854 @ $17.16 | $134,775 | 5,266,881 | 11/12/2024 | 11/13/2024 | |
|
Flynn James E
10 percent owner |
Sell | 9,554 @ $17.77 | $169,775 | 5,257,329 | 11/12/2024 | 11/13/2024 | |
|
Flynn James E
10 percent owner |
Sell | 9,553 @ $17.77 | $169,757 | 5,257,328 | 11/12/2024 | 11/13/2024 | |
|
Flynn James E
10 percent owner |
Sell | 40,596 @ $17.45 | $708,400 | 5,498,367 | 11/11/2024 | 11/13/2024 | |
|
Flynn James E
10 percent owner |
Sell | 223,632 @ $18.15 | $4.06 M | 5,274,735 | 11/11/2024 | 11/13/2024 | |
| Sell | 12,500 @ $16.00 | $200,000 | 4,949 | 10/16/2024 | 10/17/2024 | ||
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 48,550 @ $14.86 | $721,657 | 1,398,897 | 10/15/2024 | 10/17/2024 | |
|
Tanimoto Sarina
10 percent owner, CHIEF MEDICAL OFFICER |
Sell | 1,450 @ $15.25 | $22,118 | 1,397,447 | 10/15/2024 | 10/17/2024 |
ARS Pharmaceuticals, Inc. FAQ's
Who is on ARS Pharmaceuticals, Inc.'s Insider Roster?
The list of insiders at ARS Pharmaceuticals, Inc. includes Lowenthal Richard E, Tanimoto Sarina, RA CAPITAL MANAGEMENT, L.P., Karas Eric, Dorsey Brian, ORBIMED ADVISORS LLC, Thompson Peter A., Scott Kathleen D., Flynn James E, Chakma Justin, Shawver Laura.
How much insider selling is happening at ARS Pharmaceuticals, Inc.?
Insiders have sold a total of 5.27 M ARS Pharmaceuticals, Inc. shares in the last 12 months for a total of 67.01 M sold.
Which ARS Pharmaceuticals, Inc. insiders have been selling company stock?
The following insiders have sold ARS Pharmaceuticals, Inc. shares in the last 12 months: Lowenthal Richard E ($12.41 M), Tanimoto Sarina ($12.41 M), Karas Eric ($420,423), Dorsey Brian ($1.24 M), ORBIMED ADVISORS LLC ($12.59 M), Thompson Peter A. ($12.59 M), Scott Kathleen D. ($200,000), Flynn James E ($5.38 M), Chakma Justin ($7.09 M), Shawver Laura ($2.69 M),
How much insider buying is happening at ARS Pharmaceuticals, Inc.?
Insiders have purchased a total of 1.40 M ARS Pharmaceuticals, Inc. shares in the last 12 months for a total of 13.29 M.
Which ARS Pharmaceuticals, Inc. insiders have been buying company stock?
The following insiders have purchased ARS Pharmaceuticals, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($13.29 M),